ATOGEPANT (Aquipta®)

Clinical Indication

For treating acute migraine

Comments

In line with NICE TA1172

Funding from 30th July 2026

Date of classification

September 2026

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.